Start for free
Start for free
PBM Capital Group logo

PBM Capital Group

North America, Virginia, United States, Charlottesville

Description

PBM Capital Group is a private investment firm primarily focused on healthcare investments.

Investor Profile

PBM Capital Group has made 18 investments, with 1 in the past 12 months and 28% as lead.

Stage Focus

  • Series B (39%)
  • Series A (28%)
  • Post Ipo Equity (11%)
  • Series Unknown (6%)
  • Series C (6%)
  • Series D (6%)
  • Seed (6%)

Country Focus

  • United States (89%)
  • United Kingdom (11%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Life Science
  • Genetics
  • Health Care
  • Health Diagnostics
  • Biopharma
  • Pharmaceutical
  • Medical
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does PBM Capital Group frequently co-invest with?

Woodline Partners
Woodline Partners
North America, California, United States, San Francisco
Co-Investments: 3
RTW Investments
RTW Investments
North America, New York, United States, New York
Co-Investments: 2
RA Capital Management
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 3
Longwood Fund
Longwood Fund
North America, Massachusetts, United States, Boston
Co-Investments: 3
Octagon Capital Advisors
Octagon Capital Advisors
North America, New York, United States, New York
Co-Investments: 2
Perceptive Advisors
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 5
Soleus Capital
Soleus Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 4
Sands Capital Ventures
Sands Capital Ventures
North America, Virginia, United States, Arlington
Co-Investments: 6
Invus
Invus
North America, New York, United States, New York
Co-Investments: 3
Boulder Ventures
Boulder Ventures
North America, Colorado, United States, Boulder
Co-Investments: 3

Which angels does PBM Capital Group often collaborate with?

ME
Martin Edwards
Europe, England, United Kingdom
Shared Deals: 1
AU
Anders Ullman
Europe, Hallands Lan, Sweden, Kungsbacka
Shared Deals: 1
JA
Jeffrey A. Leerink
North America, Massachusetts, United States, Boston
Shared Deals: 1
Mark W. Hahn
Mark W. Hahn
North America, North Carolina, United States, Chapel Hill
Shared Deals: 1
VS
Vikas Sinha
North America, Massachusetts, United States, Boston
Shared Deals: 1
David Zaccardelli
David Zaccardelli
North America, United States
Shared Deals: 1
DE
David Ebsworth
Europe, Zurich, Switzerland, Zürich
Shared Deals: 1
CG
Chris Garabedian
North America, Massachusetts, United States, Boston
Shared Deals: 1

What are some of recent deals done by PBM Capital Group?

Blue Earth Therapeutics

Oxford, Oxfordshire, United Kingdom

Blue Earth Therapeutics is a radiopharmaceutical company that specializes in the advancement of radiotherapeutics to treat cancer patients.

Health CareMedicalPharmaceuticalTherapeutics
Series AOct 30, 2024
Amount Raised: $76,500,000
Taysha Gene Therapies

Dallas, Texas, United States

Taysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.

BiotechnologyGeneticsLife Science
Post Ipo EquityAug 14, 2023
Amount Raised: $150,000,000
LEXEO Therapeutics

New York, New York, United States

LEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.

BiotechnologyLife ScienceTherapeutics
Series BSep 9, 2021
Amount Raised: $100,000,000
Genapsys

Redwood City, California, United States

Transform the human condition by building a scalable, affordable genomic sequencing ecosystem that will support research and diagnostics

BioinformaticsBiotechnologyGeneticsHealth DiagnosticsLife Science
Series DMay 27, 2021
Amount Raised: $70,000,000
PatientsLikeMe

Boston, Massachusetts, United States

PatientsLikeMe is a personalized health network of an integrated community, health management, and real-world data platform.

Health CareInformation ServicesMedicalSoftware
Series UnknownFeb 9, 2021
Amount Raised: $26,000,000
LEXEO Therapeutics

New York, New York, United States

LEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.

BiotechnologyLife ScienceTherapeutics
Series AJan 7, 2021
Amount Raised: $85,000,000
Acumen Pharmaceuticals

Carmel, Indiana, United States

Acumen is developing targeted therapies for the safe and effective treatment of Alzheimer’s Disease and related neurodegenerative diseases.

BiotechnologyHealth DiagnosticsTherapeutics
Series BNov 20, 2020
Amount Raised: $75,000,000
Taysha Gene Therapies

Dallas, Texas, United States

Taysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.

BiotechnologyGeneticsLife Science
Series BAug 5, 2020
Amount Raised: $95,000,000
Verona Pharma

London, England, United Kingdom

Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases.

BiotechnologyPharmaceuticalTherapeutics
Post Ipo EquityJul 17, 2020
Amount Raised: $200,000,000
Taysha Gene Therapies

Dallas, Texas, United States

Taysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.

BiotechnologyGeneticsLife Science
SeedApr 29, 2020
Amount Raised: $30,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator